SOMAXON PHARMACEUTICALS, INC.
CIK 0001339455
Revenue (TTM)
$15.4M
Q3 Oct 2012
Net Income (TTM)
−$25.82M
−52.7% YoY
Q3 Oct 2012
EPS Diluted (TTM)
—
Q3 Oct 2012
Gross Margin
92.0%
Q3 Oct 2012
Operating Margin
-155.5%
Q3 Oct 2012
Net Margin
-167.6%
Q3 Oct 2012
Free Cash Flow (TTM)
−$49.9M
Q3 Oct 2012
Cash
$8.16M
Q3 Oct 2012
Total Debt
$15M
Q3 Oct 2012
Shares Outstanding
7.19M sh
Q3 Oct 2012
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.